Navigation Links
Boston Medical Center Managing H1N1 Flu Vaccination for its Community with Carefx's New Immunization Management Solution

SCOTTSDALE, Ariz., Oct. 27 /PRNewswire/ -- Acknowledging the critical role of Centers for Disease Control and Prevention (CDC) guidelines in ensuring the safety and efficacy of H1N1 vaccinations, Carefx Corporation, a leading provider of interoperable workflow solutions to advance the quality and safety of patient care, today announced that Boston Medical Center (BMC) has deployed the Fusionfx Immunization Management portal designed to enter and track H1N1 vaccination administration history and support broad, community-wide immunization administration tracking.

"Deployed in less than two weeks, the immunization management portal empowers BMC to leverage the existing consent processes and portal infrastructure of its community information exchange (CIE) to integrate vaccination information from community health centers (CHCs) and acute care facilities, and facilitate vaccination data sharing among CHCs," said Daniel Newman, M.D., BMC's Chief Medical Information Officer. "Using Carefx's solution, BMC is better able to adhere to the most appropriate H1N1 multi-dose regimen and sequence in conjunction with seasonal flu and pneumovax administration."

Whether BMC patients and employees receive their H1N1, seasonal flu and pneumovax vaccinations in emergency departments, CHCs, or inpatient facilities, the Fusionfx immunization management portal enables vaccination data to be captured, integrated with CIE data and used for reporting. The portal also captures demographic, lab and workflow data, information on H1N1, seasonal flu and pneumovax vaccinations and clinical evaluation.

"The Fusionfx immunization management portal will help BMC professionals follow CDC guidelines related to issues such as adult and pediatric dosing and required intervals between H1N1, seasonal flu and pneumovax vaccinations at the point of care," said Qi Li, M.D., Carefx's Vice President of Clinical Strategies. "With the portal, BMC can more easily verify if patients and employees have received required vaccinations and access specifics such as vaccine lot number should safety problems emerge in the future. In addition, the Fusionfx immunization management portal meets the Immunization Information Systems goals set forth by CDC."

The Fusionfx immunization management portal, which uses the same portal-based infrastructure as the Fusionfx eReferral solution that BMC deployed to manage its physician referral management process, offers both patient search and vaccination history and entry. Clinicians can search a patient by medical record number, name, age or gender. Historical vaccination information is aggregated with the CIE. The clinician can also quickly enter vaccinations administered.

Immunization tracking is top-of-mind in healthcare, not just because of the prevalence of the H1N1 virus. Immunization repositories, such as the one developed by Santa Clara County, California, have the potential to decrease duplicate immunizations, support vaccine recalls and adverse events and introduce and track new vaccines. Moreover, growing numbers of health information exchanges (HIEs), including those in Louisiana, Minnesota, Wisconsin and New York, are investigating immunization surveillance, as are large nations such as China where five percent of the approximately 1.3 billion-strong population are slated to receive the H1N1 vaccine by the end of 2009.

"The Fusionfx immunization management portal can be easily and quickly replicated in hospitals, health systems, integrated delivery networks, public health departments and HIEs," said Andy Hurd, Chairman and CEO of Carefx. "Physician executives, medical directors and materials management professionals will appreciate the value of a tool that can aggregate vaccination information from multiple sources using a common data access format."

About Boston Medical Center

Boston Medical Center is a private, not-for-profit, 626-licensed bed, academic medical center located in Boston's historic South End. The hospital is the primary teaching affiliate for Boston University School of Medicine. Emphasizing community-based care, Boston Medical Center, with its mission to provide consistently accessible health services to all, is the largest safety net hospital in New England.

About Carefx Corporation

Carefx supports healthcare organizations in achieving their vision of advancing the quality and safety of patient care delivery through its Fusionfx solution suite. Fusionfx streamlines and simplifies clinical and business workflow and connects care providers to the information they need - where, when, and how they need it. By managing care transitions and information gaps between diverse systems, departments and facilities, Fusionfx delivers crucial patient information with speed, efficiency and logic. Carefx supports more than 600 hospitals, health systems, regional health information organizations (RHIOs) and health information exchanges (HIEs) across North America and Europe.

For more information, visit, or contact Carefx at (480) 833-5010 or by email at

SOURCE Carefx Corporation

SOURCE Carefx Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Boston Scientific Announces Results for Third Quarter Ended September 30, 2009
2. Boston Scientific to Webcast Conference Call Discussing Third Quarter Financial Results
3. Boston Scientific Announces FDA Clearance and U.S. and European Availability of WallFlex(R) Biliary RX Covered Stents
4. Boston Business Journal Names NxStage(R) Medical Third Fastest Growing Company in Massachusetts
5. Boston Scientific and Johnson & Johnson Announce Settlement of Patent Disputes
6. The 60th Annual Meeting of the American Association for the Study of Liver Diseases Boston, MA -- Hynes Convention Center October 31 -- November 3, 2009
7. SPIRIT IV Results Reaffirm Strong Performance of Boston Scientific PROMUS(R) and TAXUS(R) Express(R) Stents
8. Boston Scientific Announces Schedule for European Society of Cardiology Congress
9. Boston Scientific Welcomes Results of Brain Aneurysm Clinical Trial
10. Boston Scientific Begins Clinical Trial for Next-Generation Nitinol Stent to Treat Iliac Artery Disease
11. Boston Scientific Launches Third-Generation Platinum Chromium Drug-Eluting Stent
Post Your Comments:
(Date:10/4/2017)... , Oct. 4, 2017 OBP ... self-contained, illuminating medical devices, today announced regulatory approval ... Surveillance Agency (or Agência Nacional de Vigilância Sanitária ... single-use, cordless surgical retractor with integrated LED light ... access, illumination and exposure of a tissue pocket ...
(Date:10/2/2017)... INDIANAPOLIS , Oct. 2, 2017  Eli Lilly ... its financial results for the third quarter of 2017 ... a conference call on that day with the investment ... performance. The conference call will begin at ... public can access a live webcast of the conference ...
(Date:10/2/2017)... , Oct. 2, 2017 Halo Labs announces the European ... system called the HORIZON at MIBio 2017 in Cambridge, ... and visible particulate matter in biopharmaceutical samples with unprecedented speed and ... the novel technique Backgrounded Membrane Imaging. ... The HORIZON subvisible particle analysis system ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance that covers ... companies have a waiver for care if the client has a cognitive impairment diagnosis. ... pays for care, is often waived, so the benefits from their insurance start immediately,” ...
(Date:10/13/2017)... Abilene, Texas (PRWEB) , ... October 13, 2017 , ... ... publication this week that explains one of the most popular and least understood books ... seems like cryptic and puzzling descriptions that have baffled scholars for centuries. Many have ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... “America On ... Christian identity. “America On The Brink” is the creation of published author, William ... several great-grandchildren. As a WWII veteran, he spent thirty years in the Navy. ...
(Date:10/12/2017)... ... 12, 2017 , ... The company has developed a suite ... regulatory authorities worldwide. From Children’s to Adults 50+, every formula has been developed ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... drug delivery system that we intend to develop to enable prevention of a ... lead to severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss ...
Breaking Medicine News(10 mins):